Add BrightSurf on Google Email

ASCO & NEJM: AI plus ovarian suppression yields benefit in high-risk younger breast cancer patients

A new clinical trial analysis found that combining an aromatase inhibitor with ovarian function suppression yields a 10-15% improvement in freedom from distant recurrence for high-risk younger breast cancer patients. Women at low risk saw minimal benefit, while those at intermediate risk gained a 4-5% advantage.

SourceDana-Farber Cancer Institute·JournalNew England Journal of Medicine·DateJun 4, 2018

Study reveals that many oncologists recommend medical marijuana clinically despite not feeling sufficiently knowledgeable to do so

Researchers found that most oncologists discuss medical marijuana with patients and nearly half recommend it, but only 30% feel knowledgeable enough to make recommendations. The study suggests a discrepancy between attitudes and practices regarding medical marijuana's utility in oncology.

SourceDana-Farber Cancer Institute·JournalJournal of Clinical Oncology·DateMay 10, 2018

CRISPR enhances cancer immunotherapy

Researchers at WashU Medicine used CRISPR to engineer human T cells that can attack human T cell cancers without succumbing to friendly fire. The new approach also allows for the use of therapeutic T cells from any healthy donor, eliminating the need for a matched donor or patient's own T cells.

SourceWashU Medicine·JournalLeukemia·DateMar 6, 2018

Clinical trial reveals genetic fault that reduces the effectiveness of leukemia treatment

A genetic fault in the CDKN2A gene has been linked to reduced effectiveness of leukemia treatment, highlighting the need for personalized treatment approaches. The study, which treated 259 people with AML or MDS, found that those with the mutation survived for 4.5 months on average, compared to 11 months for those without it.

SourceUniversity of Birmingham·JournalClinical Cancer Research·DateSep 26, 2017

Melatonin may help treat blood cancers

Researchers found melatonin boosts immune response against cancer cells, inhibits growth and protects healthy cells from chemotherapy effects. Timing of melatonin treatments is crucial for their anticancer effects due to its role in regulating circadian rhythms.

SourceWiley·JournalBritish Journal of Pharmacology·DateSep 1, 2017

Why fewer blood cancer patients receive hospice care

Research shows that blood cancer patients are less likely to enroll in hospice care compared to solid cancer patients. However, a survey of hematologic oncologists found that 68% agree that hospice care is helpful for blood cancer patients, and most would refer patients if red blood cell transfusions were available.

SourceWiley·JournalCancer·DateMay 22, 2017

Raised blood platelet levels 'strong predictor' of cancer

A large-scale study found that raised blood platelet counts are a strong predictor of cancer, with lung and colorectal cancers being more commonly diagnosed. The research suggests that substantial numbers of people could have their cancer diagnosed up to three months earlier if thrombocytosis prompted investigation.

SourceUniversity of Exeter·JournalBritish Journal of General Practice·DateMay 22, 2017

Genetic profiling can guide stem cell transplantation for patients with myelodysplastic syndrome

Researchers discovered genetic mutations in TP53, RAS pathway genes, and JAK2 gene associated with shorter survival and increased relapse risk after stem cell transplant. The findings provide a guide for identifying patients most likely to benefit from a transplant, enabling personalized treatment strategies.

SourceDana-Farber Cancer Institute·JournalNew England Journal of Medicine·DateFeb 8, 2017